470pa Phase I Study of Eribulin and Gemcitabine in Patients with Avanced Solid Tumours. a Study of the Princess Margaret Phase Ii Consortium.

R. Goel1, S. Lheureux2, S.A. Laurie1, R.A. Halford2, D. Jonker1, E.X. Chen2, D. Keller3, V. Bourada3, L. Wang4, L.A. Doyle5, L.L. Siu6, A.M. Oza7 Medicine, The Ottawa Hospital, Ottawa, ON, CANADA Drug Development Program, Princess Margaret Cancer Centre, Toronto, ON, CANADA Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, CANADA Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, CANADA Investigational Drug Branch (ctep), National Cancer Institute, Bethesda, MD, USA Drug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, CANADA Drug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, CANADA